Nav: Home

Study suggests new way to help the immune system fight off parasite

December 08, 2015

Some infectious diseases are particularly difficult to treat because of their ability to evade the immune system. One such illness, African sleeping sickness, is caused by the parasite Trypanosoma brucei, transmitted by the tsetse fly, and is fatal if left untreated. The trypanosome parasite is transmitted to mammals through fly bites and eventually invades major organs such as the brain, disrupting the sleep cycle, among other symptoms.

Trypanosomes exist in different forms. When inhabiting a fly, they are covered with proteins called procyclins. Upon entering the bloodstream of a mammal, they acquire a dense layer of glycoproteins that continually change, allowing the parasite to dodge an attack from the host's immune system.

Now, new research from postdoctoral scientists Danae Schulz and Erik Debler, working in the Papavasiliou and Blobel labs at Rockefeller University, reveals a method to manipulate trypanosomes in the mammalian bloodstream to acquire fly stage characteristics, a state that makes it easier for the host immune system to eliminate the invader. The findings suggest that inhibiting specific proteins that interact with chromatin--the mass of DNA and proteins that packages a cell's genetic information--can "trick" the parasite into differentiating to a different stage of its lifecycle. The study is publishing on December 8 in the Open Access journal PLOS Biology.

"By blocking these chromatin-interacting proteins, we have found a way to make the parasite visible to the immune system," says Nina Papavasiliou, head of the Laboratory of Lymphocyte Biology. "The bloodstream form of the parasite is constantly switching protein coats, so the immune system can't recognize and eliminate it. This new method makes the parasite think it's in the fly, where it doesn't need to worry about the immune system attacking it."

Epigenetic regulation

Regulatory proteins interact with chromatin to either unwind it or package it more tightly, affecting which genes are expressed. Some of these regulatory proteins contain a region called the bromodomain, which recognizes a specific signal on chromatin and induces changes in gene expression.

Recent findings in mice have indicated that bromodomains are involved in cell differentiation, which led Papavasiliou and colleagues to hypothesize that such epigenetic mechanisms may drive the trypanosome to change from one form to another.

"The changes in gene expression that accompany the transition between the different parasite forms had been well established," said lead author of the study, Danae Schulz. "But we didn't understand if there was some type of regulation happening at DNA, at the level of chromatin. Whether chromatin altering mechanisms might be important for differentiation hadn't really been studied before."

To investigate this, the researchers inhibited bromodomain proteins in cells by introducing genetic mutations in their DNA or by exposing the cells to a small-molecule drug called I-BET151, which is known to block bromodomains in mammals. When these perturbations were made, the investigators observed changes in gene expression levels that resembled those seen in cells differentiating from the bloodstream form to the fly form. They also saw that the parasites developed a procyclin coat normally found on the fly form.

Based on these findings, Papavasiliou and colleagues suggest that proteins with bromodomains maintain the bloodstream form of trypanosomes, and inhibiting them causes the parasite to progress in development toward the fly form. They believe that bromodomains could serve as a potential therapeutic target to treat African sleeping sickness.

Harnessing the natural immune system

To explore whether I-BET151 could be used to combat the disease, the researchers used drug treated-trypanosomes to infect mice. The mice infected with drug-treated trypanosomes survived significantly longer than mice that were not treated, indicating that the virulence of the parasite--its ability to invade the host--was diminished in the presence of I-BET151.

"When bromodomains are inhibited, the variant protein coat is replaced with an unvarying coat on the surface of the trypanosome cell," says Schulz. "This means that the parasite surface is no longer a moving target, giving the immune system enough time to eliminate it."

I-BET151 is not effective enough to be used in the clinic, but a crystal structure determined by Erik Debler and published as part of this study provides direct clues for how an optimized drug could be designed to bind parasite bromodomains in a highly specific manner, limiting side effects.

"Current treatments for this disease are limited and they have substantial side effects, including very high mortality rates," says Papavasiliou. "This study, and recent work by others, demonstrates that targeting chromatin-interacting proteins offers a promising new avenue to develop therapeutics. This could apply not only to African sleeping sickness, but to a number of related parasitic diseases like Chagas or malaria, with disease burdens that are far more substantial than those caused by Trypanosoma brucei."
-end-
Please mention PLOS Biology as the source for this article and include the links below in your coverage to take readers to the online, open access articles.

All works published in PLOS Biology are open access, which means that everything is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002316

Contact: Katherine Fenz
Media Relations Manager
The Rockefeller University, New York
212-327-7913

Citation: Schulz D, Mugnier MR, Paulsen E-M, Kim H-S, Chung C-wW, Tough DF, et al. (2015) Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome. PLoS Biol 13(12): e1002316. doi:10.1371/journal.pbio.1002316

Funding: DS is supported by an NIH postdoctoral fellowship (NIH/GM103214) and EWD was a Frey

Fellow of the Damon Runyon Cancer Research Foundation. This work was funded by a Bill and Melinda Gates Foundation GCE grant to DS and EWD (CEN5401889), and NIH/NIAID grant AI085973 to FNP. Data were measured at beamline X29 at NSLS, supported by NIH grants P41GM103473 and P30-EB-00998. IR, DFT, RKP and CWC are employees of GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests. IR, DT, RP, and CC are employees of GlaxoSmithKline, but should have no competing interests in the context of the work presented here.

PLOS

Related Immune System Articles:

The immune system may explain skepticism towards immigrants
There is a strong correlation between our fear of infection and our skepticism towards immigrants.
New insights on how pathogens escape the immune system
The bacterium Salmonella enterica causes gastroenteritis in humans and is one of the leading causes of food-borne infectious diseases.
Understanding how HIV evades the immune system
Monash University (Australia) and Cardiff University (UK) researchers have come a step further in understanding how the human immunodeficiency virus (HIV) evades the immune system.
Carbs during workouts help immune system recovery
Eating carbohydrates during intense exercise helps to minimise exercise-induced immune disturbances and can aid the body's recovery, QUT research has found.
A new model for activation of the immune system
By studying a large protein (the C1 protein) with X-rays and electron microscopy, researchers from Aarhus University in Denmark have established a new model for how an important part of the innate immune system is activated.
Guards of the human immune system unraveled
Dendritic cells represent an important component of the immune system: they recognize and engulf invaders, which subsequently triggers a pathogen-specific immune response.
How our immune system targets TB
Researchers have seen, for the very first time, how the human immune system recognizes tuberculosis (TB).
How a fungus inhibits the immune system of plants
A newly discovered protein from a fungus is able to suppress the innate immune system of plants.
A new view of the immune system
Pathogen epitopes are fragments of bacterial or viral proteins. Nearly a third of all existing human epitopes consist of two different fragments.
TB tricks the body's immune system to allow it to spread
Tuberculosis tricks the immune system into attacking the body's lung tissue so the bacteria are allowed to spread to other people, new research from the University of Southampton suggests.

Related Immune System Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...